← Back to Search

Cognitive Behavioural Therapy-Ten for Eating Disorders

N/A

Waitlist Available

Led By Elizabeth Phoenix

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e

Awards & highlights

Study Summary

This trial will compare two types of cognitive behavioural therapy for people with eating disorders who are not underweight. The goal is to see which therapy is more effective and has less drop-out.

Eligible Conditions

Eating Disorders

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-treatment; post-treatment (on average 10 weeks for cbt-t and 25 weeks for cbt-e) 3, 6, 12, 24 months post treatment. treatment is on average 10 weeks for cbt-t and 25 weeks for cbt-e for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Eating Disorder Cognitions

Change in the frequency of Binge Eating

Change in the frequency of Vomiting

Secondary outcome measures

Binge Eating Change over the Course of Treatment

Change in Depression symptoms

Change in Impulsivity

+6 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CBT-TExperimental Treatment1 Intervention

Participants will be randomly assigned to one of two conditions (CBT-E or CBT-T). Participants who agree to participate will receive 10 weeks of CBT-T.

Group II: CBT-EActive Control1 Intervention

Participants will be randomly assigned to one of two conditions (CBT-E or CBT-T). CBT-E will occur over the course of 25 weeks and be delivered as it typically is in the clinic setting of the investigators.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor

656 Previous Clinical Trials

413,368 Total Patients Enrolled

University of Western Ontario, CanadaOTHER

164 Previous Clinical Trials

319,186 Total Patients Enrolled

Elizabeth PhoenixPrincipal InvestigatorLondon Health Sciences Centre

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is the research team surveying in this clinical experiment?

"Affirmative. Perusal of clinicaltrials.gov reveals that recruitment is underway for this experiment, which was initially posted on June 15th 2021 and last updated on May 16th 2022. The trial aims to secure 60 participants from a single medical centre."

Answered by AI

Is registration currently open for this research program?

"According to the information provided on clinicaltrials.gov, this health study is currently recruiting participants, with its inception posted on June 15th 2021 and last updated on May 16th 2022."

Answered by AI

What objectives is this experiment attempting to fulfill?

"This clinical trial's primary outcome will be Change in Binge eating Frequency, observed over a predetermined span of time; on average this is 10 weeks for CBT-T and 25 weeks for CBT-E. Secondary outcomes include: Change in overall perceived quality of life as assessed by the WHOQOL-BREF scale; Change in Motivation as evaluated with Geller et al.'s Readiness and Motivation Questionnaire, where higher scores indicate greater readiness to modify symptoms; and Vomiting Change over Treatment duration tracked via Tatham et al.'s Eating disorder - 15 questionnaire."

Answered by AI